New Non-invasive Modalities for Assessing Retinal Structure and Function
This study is testing a new device called LSFG-NAVI to look at the blood flow in your eyes. It aims to see if this device can better detect problems in the retina (the light-sensitive tissue at the back of your eye) compared to other vision tests. You might be able to join if you are between 18 and 99 years old and have certain eye conditions like Ischemic Optic Neuropathy (damage to the optic nerve from lack of blood flow) or Leber Hereditary Optic Neuropathy (an inherited vision loss condition). People with normal eye exams can also participate as a control group. The main goal is to measure ocular blood flow (blood flow in the eye) on the first day of the study.
- Study design
- This is an interventional study with an enrollment goal of 500 participants. It is not specified if it is randomized or blinded.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Ocular blood flow is measured at 1 day, but further follow-up is not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
New Non-invasive Modalities for Assessing Retinal Structure and Function
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Randy H Kardon, MD, PhD · PRINCIPAL_INVESTIGATOR · University of Iowa Department of Ophthalmology
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Ocular Blood Flow1 day
imaging the movement of blood through blood vessels in retina and optic nerve